Amarande Murisier

Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins

Valentina D’Atri, Amarande Murisier, Szabolcs Fekete et al. · TrAC Trends in Analytical Chemistry · 2020 · 53 citations · Full text

Reversed-phase Liquid Chromatography, Rplc Stationary Phases, Protein Phase Separation +19

Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities

Elsa Wagner, Olivier Colas, Stéphane Chenu et al. · Journal of Pharmaceutical and Biomedical Analysis · 2020 · 42 citations

Immunocytochemical Technique, Autoimmune Disease, Variant Interpretation +11

Towards a simple on-line coupling of ion exchange chromatography and native mass spectrometry for the detailed characterization of monoclonal antibodies

Amarande Murisier, Bastiaan L. Duivelshof, Szabolcs Fekete et al. · Journal of Chromatography A · 2021 · 42 citations · Full text

Immunology, Biological Mass Spectrometry, Immunotherapy +23

Tuning selectivity in cation-exchange chromatography applied for monoclonal antibody separations, part 1: Alternative mobile phases and fine tuning of the separation

Evelin Farsang, Amarande Murisier, Krisztián Horváth et al. · Journal of Pharmaceutical and Biomedical Analysis · 2019 · 35 citations

Part 1, Engineering, Biochemistry +14

Ultra-short ion-exchange columns for fast charge variants analysis of therapeutic proteins

J.A. Navarro-Huerta, Amarande Murisier, Jennifer M. Nguyen et al. · Journal of Chromatography A · 2021 · 24 citations

Molecular Docking, Biochemistry, Protein Folding +9